Sources

4 Total Sources

Arrowhead Wins Phase 3 Plozasiran Trial in Severe Hypertriglyceridemia, Pressuring Ionis Shares

Right100%

Seeking Alpha10h ago

Arrowhead Pharmaceuticals' Plozasiran Achieves Late-Stage Trial Win for Severe Hypertriglyceridemia

MD Magazine10h ago

Plozasiran Meets Primary Endpoint in SHASTA-3, SHASTA-4 sHTG Trials | HCPLive

GuruFocus.com10h ago

Arrowhead Pharmaceuticals (ARWR) Achieves Late-Stage Trial Succe

Managed Healthcare Executive10h ago

Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia | Managed Healthcare Executive